'Last Mile' Initiative Overview

NCI Cervical Cancer ‘Last Mile’ Initiative (LMI)

Goal: Overcome barrier of lack of FDA approval for self-collection approaches for HPV testing-based cervical cancer screening

Approach: Engage public and private sector stakeholders to facilitate regulatory approvals for self-collection

Outcome: Increase screening access and reduce cervical cancer incidence in underserved and high-burden populations